Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-06-17
2010-11-23
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S055300, C514S056000
Reexamination Certificate
active
07838644
ABSTRACT:
A new method is described for the oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which, by subsequent N-sulfation, provides new epiK5-N,O-oversulfate-derivatives with a sulfation degree of at least 4, basically free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field. Also described are new low molecular weight epiK5-N-sulfates useful as intermediates in the preparation of the corresponding LMW-epiK5-N,O-oversulfate-derivatives.
REFERENCES:
patent: 5071969 (1991-12-01), van Boeckel et al.
patent: 5798356 (1998-08-01), Doshi
patent: 6388060 (2002-05-01), Guo et al.
patent: 2002/0062019 (2002-05-01), Oreste et al.
patent: WO 9842754 (1998-10-01), None
Leali et al. The Journal of Biological Chemistry, vol. 276, No. 41, Issue of Oct. 12, pp. 37900-37908, 2001.
Baba et al. The Journal of Infectious Diseases 1990; 161:208-213.
Barrowcliffe et al. “The anticoagulant activity of heparin: Measurement and relationship to chemical structure” J. Pharmaceut. & Biomed. Anal. 7:217-226 (1989).
Hemker et al. “Elements from in vitro studies that help understand the action of heparins” Thrombosis Res. Suppl. 14:1-10 (1991).
Klein et al. “Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: A comparison with anti-Xa concentrations” Anesth. Analg. 91:1091-1095 (2000).
Lembo et al. “Sulfated K5Escherichia colipolysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus” Antimicrob. Agents Chemother. 52:1374-1381 (Apr. 2008).
Pinna et al. “Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives ofEscherichia coliK5 polysaccharide” Antimicrob. Agents Chemother. 52:3078-3084 (Sep. 2008).
Razi et al. “Structural and functional properties of heparin analogues obtained by chemical sulphation ofEscherichia coilK5 capsular polysaccharide” Biochem. J., 309:465-479 (1995).
Vicenzi et al. “Broad spectrum inhibition of HIV-1 infection by sulfated K5Escherichia colipolysaccharide derivatives” AIDS 17:177-181 (Jan. 2003).
Oreste Pasqua Anna
Zoppetti Giorgio
Bland Layla
Glycores 2000 S.R.L.
Jiang Shaojia Anna
Nixon & Vanderhye P.C.
LandOfFree
Epimerized derivatives of K5 polysaccharide with a very high... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epimerized derivatives of K5 polysaccharide with a very high..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epimerized derivatives of K5 polysaccharide with a very high... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177106